Corporate / M&A

Regulatory

Homburger News

20250320_UBS

Homburger advised UBS on the merger of pension foundations

In December 2024, UBS took another step in the integration of Credit Suisse and closed the mergers of the vested benefits foundations (Pillar 2 &#8211; FZG) of UBS and Credit Suisse as well as of the Pillar 3a foundations of UBS and Credit Suisse. These mergers ensure that all beneficiaries of the foundations have equal access to the service offerings of UBS.
The Homburger team advising on the mergers comprised Andreas Müller, Francesco Bernasconi and Thierry Burckhardt (all Corporate / M&amp;A) and Peter Müller (Tax / Pensions).

Homburger advised UBS on the merger of pension foundations 

Financial Market Regulation

Employment and Executive Compensation

Miller Insurance_640x140

Share-Image Teamplate Deals-and-Cases

On August 1, 2024, Miller, the leading independent specialist (re)insurance broker, announced the acquisition of the Zug-based reinsurance capital advisory business 4809 Brokers AG. The acquisition forms part of Miller’s continued international expansion and is consistent with Miller’s reinsurance strategy, which is focused on growth opportunities in the value-add and advisory parts of the market.
The Homburger team was led by Daniel Hasler and Hansjürg Appenzeller (both Corporate / M&amp;A) and included Francesco Bernasconi and Matthias Müller (both Corporate / M&amp;A), Fabrice Eckert (Financial Market Regulation) as well as Jeremy Reichlin (Employment and Executive Compensation).

Homburger advised Miller Insurance on its acquisition of the reinsurance capital advisory business 4809 Brokers AG 

Healthcare / Life Sciences

Tolremo-web-640x140

On September 20, 2023, TOLREMO therapeutics AG announced that it has completed its Series A financing, bringing the total amount raised to USD 39 m (CHF 34.1 m). BioMedPartners AG led the round with participation from a new investor, Pierre Fabre Invest, as well as existing investors.
TOLREMO&#8217;s mission is to stop non-genetic cancer drug resistance as it emerges by dismantling cancer&#8217;s earliest defenses to targeted therapies, thus surmounting a universal challenge for current and future targeted treatments.
The Homburger team was led by Dieter Gericke and Margrit Marti and comprised Francesco Bernasconi, Stefan Luginbühl, Thierry Burckhardt and Claudine Schär (all Corporate / M&amp;A; Healthcare / Life Sciences) as well as Stefan Oesterhelt (Tax).

Homburger advised TOLREMO therapeutics AG on the extension of its Series A financing round

Francesco
Bernasconi

Homburger advised UBS on the merger of pension foundations

Homburger advised Miller Insurance on its acquisition of the reinsurance capital advisory business 4809 Brokers AG

Homburger advised TOLREMO therapeutics AG on the extension of its Series A financing round

Unzulässigkeit von erleichterten Fusionen nach Art. 23 Abs. 1 lit. b FusG bei indirekten Beteiligungsverhältnissen

Join the Team

Francesco Bernasconi

Career

Languages

Bar Registration

Teams

FrancescoBernasconi

Homburger advised UBS on the merger of pension foundations

Homburger advised Miller Insurance on its acquisition of the reinsurance capital advisory business 4809 Brokers AG

Homburger advised TOLREMO therapeutics AG on the extension of its Series A financing round

Unzulässigkeit von erleichterten Fusionen nach Art. 23 Abs. 1 lit. b FusG bei indirekten Beteiligungsverhältnissen

Join the Team

Francesco Bernasconi

Career

Languages

Bar Registration

Teams

Francesco
Bernasconi

Unzulässigkeit von erleichterten Fusionen nach Art. 23 Abs. 1 lit. b FusG bei indirekten Beteiligungsverhältnissen